{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:23:25Z","timestamp":1790965405684,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Sj\u00f6gren syndrome (SjS) is a systemic autoimmune disease in which an immunological attack primarily against the salivary and lacrimal glands results in the loss of acinar cell tissue and function, leading to stomatitis sicca and keratoconjunctivitis sicca. In recent years, two genetic regions, one on chromosome 1 (designated autoimmune exocrinopathy 2 or <jats:italic>Aec2<\/jats:italic>) and the second on chromosome 3 (designated autoimmune exocrinopathy 1 or <jats:italic>Aec1<\/jats:italic>) derived from nonobese diabetic (NOD) mice, have been shown to be necessary and sufficient to replicate SjS-like disease in nonsusceptible C57BL\/6 mice.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Starting with the SjS-susceptible C57BL\/6-derived mouse, referred to as C57BL\/6.NOD-<jats:italic>Aec1Aec2<\/jats:italic>, we generated a large set of recombinant inbred (RI) lines containing portions of <jats:italic>Aec2<\/jats:italic> as a means of identifying more precisely the genetic elements of chromosome 1 responsible for disease development.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Disease profiling of these RI lines has revealed that the SjS susceptibility genes of <jats:italic>Aec2<\/jats:italic> lie within a region located at approximately 79 \u00b1 5 cM distal to the centromere, as defined by microsatellite markers. This chromosomal region contains several sets of genes known to correlate with various immunopathological features of SjS as well as disease susceptibility genes for both type 1 diabetes and systemic lupus erythematosus in mice. One gene in particular, tumor necrosis factor (ligand) superfamily member 4 (or <jats:italic>Ox40 ligand<\/jats:italic>), encoding a product whose biological functions correlate with both physiological homeostasis and immune regulations, could be a potential candidate SjS susceptibility gene.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>These new RI lines represent the first step not only in fine mapping SjS susceptibility loci but also in identifying potential candidate SjS susceptibility genes. Identification of possible candidate genes permits construction of models describing underlying molecular pathogenic mechanisms in this model of SjS and establishes a basis for construction of specific gene knockout mice.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2560","type":"journal-article","created":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T19:14:25Z","timestamp":1227640465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification of possible candidate genes regulating Sj\u00f6gren's syndrome-associated autoimmunity: a potential role for TNFSF4in autoimmune exocrinopathy"],"prefix":"10.1186","volume":"10","author":[{"given":"Cuong Q","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet G","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joann","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammon B","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"2402_CR1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-857X(21)00314-8","volume":"18","author":"RI Fox","year":"1992","unstructured":"Fox RI, Kang HI: Pathogenesis of Sj\u00f6gren's syndrome. Rheum Dis Clin North Am. 1992, 18: 517-538.","journal-title":"Rheum Dis Clin North Am"},{"key":"2402_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00002281-200309000-00007","volume":"15","author":"A Hansen","year":"2003","unstructured":"Hansen A, Lipsky PE, Dorner T: New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr Opin Rheumatol. 2003, 15: 563-570. 10.1097\/00002281-200309000-00007.","journal-title":"Curr Opin Rheumatol"},{"key":"2402_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/030097400447525","volume":"29","author":"R Jonsson","year":"2000","unstructured":"Jonsson R, Haga HJ, Gordon TP: Current concepts on diagnosis, autoantibodies and therapy in Sj\u00f6gren's syndrome. Scand J Rheumatol. 2000, 29: 341-348. 10.1080\/030097400447525.","journal-title":"Scand J Rheumatol"},{"key":"2402_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2741\/2187","volume":"12","author":"CQ Nguyen","year":"2007","unstructured":"Nguyen CQ, Cha SR, Peck AB: Sj\u00f6gren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Front Biosci. 2007, 12: 1767-1789. 10.2741\/2187.","journal-title":"Front Biosci"},{"key":"2402_CR5","first-page":"1","volume":"29","author":"S Makino","year":"1980","unstructured":"Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980, 29: 1-13.","journal-title":"Jikken Dobutsu"},{"key":"2402_CR6","first-page":"1071","volume":"32","author":"YT Konttinen","year":"2005","unstructured":"Konttinen YT, Tensing EK, Laine M, Porola P, Tornwall J, Hukkanen M: Abnormal distribution of aquaporin-5 in salivary glands in the NOD mouse model for Sj\u00f6gren's syndrome. J Rheumatol. 2005, 32: 1071-1075.","journal-title":"J Rheumatol"},{"key":"2402_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2249.2005.02930.x","volume":"142","author":"F Rosignoli","year":"2005","unstructured":"Rosignoli F, Roca V, Meiss R, Leceta J, Gomariz RP, Perez Leiros C: Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis. Clin Exp Immunol. 2005, 142: 411-418.","journal-title":"Clin Exp Immunol"},{"key":"2402_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/978-1-4615-2417-5_105","volume":"350","author":"MG Humphreys-Beher","year":"1994","unstructured":"Humphreys-Beher MG, Hu Y, Nakagawa Y, Wang PL, Purushotham KR: Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sj\u00f6gren's syndrome. Adv Exp Med Biol. 1994, 350: 631-636.","journal-title":"Adv Exp Med Biol"},{"key":"2402_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-3083.2006.01828.x","volume":"64","author":"C Nguyen","year":"2006","unstructured":"Nguyen C, Singson E, Kim JY, Cornelius JG, Attia R, Doyle ME, Bulosan M, Cha S, Peck AB: Sj\u00f6gren's syndrome-like disease of C57BL\/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus. Scand J Immunol. 2006, 64: 295-307. 10.1111\/j.1365-3083.2006.01828.x.","journal-title":"Scand J Immunol"},{"key":"2402_CR10","first-page":"1896","volume":"27","author":"J Brayer","year":"2000","unstructured":"Brayer J, Lowry J, Cha S, Robinson CP, Yamachika S, Peck AB, Humphreys-Beher MG: Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sj\u00f6gren's syndrome-like autoimmune exocrinopathy. J Rheumatol. 2000, 27: 1896-1904.","journal-title":"J Rheumatol"},{"key":"2402_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","volume":"54","author":"JB Brayer","year":"2001","unstructured":"Brayer JB, Cha S, Nagashima H, Yasunari U, Lindberg A, Diggs S, Martinez J, Goa J, Humphreys-Beher MG, Peck AB: IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sj\u00f6gren's syndrome. Scand J Immunol. 2001, 54: 133-140. 10.1046\/j.1365-3083.2001.00958.x.","journal-title":"Scand J Immunol"},{"key":"2402_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","volume":"60","author":"S Cha","year":"2004","unstructured":"Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB: A dual role for interferon-gamma in the pathogenesis of Sj\u00f6gren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol. 2004, 60: 552-565. 10.1111\/j.0300-9475.2004.01508.x.","journal-title":"Scand J Immunol"},{"key":"2402_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/154411130201300103","volume":"13","author":"S Cha","year":"2002","unstructured":"Cha S, Peck AB, Humphreys-Beher MG: Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update. Crit Rev Oral Biol Med. 2002, 13: 5-16. 10.1177\/154411130201300103.","journal-title":"Crit Rev Oral Biol Med"},{"key":"2402_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000049194","volume":"18","author":"S Cha","year":"2001","unstructured":"Cha S, van Blockland SC, Versnel MA, Homo-Delarche F, Nagashima H, Brayer J, Peck AB, Humphreys-Beher MG: Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp Clin Immunogenet. 2001, 18: 143-160. 10.1159\/000049194.","journal-title":"Exp Clin Immunogenet"},{"key":"2402_CR15","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/art.20371","volume":"50","author":"J Gao","year":"2004","unstructured":"Gao J, Cha S, Jonsson R, Opalko J, Peck AB: Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sj\u00f6gren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum. 2004, 50: 2615-2621. 10.1002\/art.20371.","journal-title":"Arthritis Rheum"},{"key":"2402_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","volume":"26","author":"J Gao","year":"2006","unstructured":"Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB: Sj\u00f6gren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun. 2006, 26: 90-103. 10.1016\/j.jaut.2005.11.004.","journal-title":"J Autoimmun"},{"key":"2402_CR17","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","volume":"95","author":"CP Robinson","year":"1998","unstructured":"Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, Peen E, Jonsson R, Humphreys-Beher MG: Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sj\u00f6gren's syndrome. Proc Natl Acad Sci USA. 1998, 95: 7538-7543. 10.1073\/pnas.95.13.7538.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2402_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/978-1-4615-5359-5_68","volume":"438","author":"CP Robinson","year":"1998","unstructured":"Robinson CP, Cornelius J, Bounous DI, Yamamoto H, Humphreys-Beher MG, Peck AB: Infiltrating lymphocyte populations and cytokine production in the salivary and lacrimal glands of autoimmune NOD mice. Adv Exp Med Biol. 1998, 438: 493-497.","journal-title":"Adv Exp Med Biol"},{"key":"2402_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/clin.1996.0050","volume":"79","author":"CP Robinson","year":"1996","unstructured":"Robinson CP, Yamamoto H, Peck AB, Humphreys-Beher MG: Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol. 1996, 79: 50-59. 10.1006\/clin.1996.0050.","journal-title":"Clin Immunol Immunopathol"},{"key":"2402_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","volume":"41","author":"CP Robinson","year":"1998","unstructured":"Robinson CP, Yamachika S, Bounous DI, Brayer J, Jonsson R, Holmdahl R, Peck AB, Humphreys-Beher MG: A novel NOD-derived murine model of primary Sj\u00f6gren's syndrome. Arthritis Rheum. 1998, 41: 150-156. 10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T.","journal-title":"Arthritis Rheum"},{"key":"2402_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/art.10258","volume":"46","author":"S Cha","year":"2002","unstructured":"Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG: Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sj\u00f6gren's syndrome) on a healthy murine background. Arthritis Rheum. 2002, 46: 1390-1398. 10.1002\/art.10258.","journal-title":"Arthritis Rheum"},{"key":"2402_CR22","first-page":"353","volume":"49","author":"JB Brayer","year":"2001","unstructured":"Brayer JB, Humphreys-Beher MG, Peck AB: Sj\u00f6gren's syndrome: immunological response underlying the disease. Arch Immunol Ther Exp (Warsz). 2001, 49: 353-360.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2402_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.2885918","volume":"237","author":"M Prochazka","year":"1987","unstructured":"Prochazka M, Leiter EH, Serreze DV, Coleman DL: Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science. 1987, 237: 286-289. 10.1126\/science.2885918.","journal-title":"Science"},{"key":"2402_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/1074-7613(94)90100-7","volume":"1","author":"L Morel","year":"1994","unstructured":"Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK: Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1994, 1: 219-229. 10.1016\/1074-7613(94)90100-7.","journal-title":"Immunity"},{"key":"2402_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH: Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002, 61: 554-558. 10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"key":"2402_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/ard.58.10.623","volume":"58","author":"N Pourmand","year":"1999","unstructured":"Pourmand N, Wahren-Herlenius M, Gunnarsson I, Svenungsson E, Lofstrom B, Ioannou Y, Isenberg DA, Magnusson CG: Ro\/SSA and La\/SSB specific IgA autoantibodies in serum of patients with Sj\u00f6gren's syndrome and systemic lupus erythematosus. Ann Rheum Dis. 1999, 58: 623-629. 10.1136\/ard.58.10.623.","journal-title":"Ann Rheum Dis"},{"key":"2402_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/jaut.1993.1032","volume":"6","author":"R Maran","year":"1993","unstructured":"Maran R, Dueymes M, Pennec YL, Casburn-Budd R, Shoenfeld Y, Youinou P: Predominance of IgG1 subclass of anti-Ro\/SSA, but not anti-La\/SSB antibodies in primary Sj\u00f6gren's syndrome. J Autoimmun. 1993, 6: 379-387. 10.1006\/jaut.1993.1032.","journal-title":"J Autoimmun"},{"key":"2402_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/gut.2004.047142","volume":"54","author":"L Aparisi","year":"2005","unstructured":"Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, Ferrandez A, Bautista D, Perez-Mateo M, Mery S, Sastre J: Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005, 54: 703-709. 10.1136\/gut.2004.047142.","journal-title":"Gut"},{"key":"2402_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/art.1780290207","volume":"29","author":"JB Harley","year":"1986","unstructured":"Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, Yamagata H, Arnett FC: Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sj\u00f6gren's syndrome. Arthritis Rheum. 1986, 29: 196-206. 10.1002\/art.1780290207.","journal-title":"Arthritis Rheum"},{"key":"2402_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/jcp.52.9.684","volume":"52","author":"W Pollock","year":"1999","unstructured":"Pollock W, Toh BH: Routine immunofluorescence detection of Ro\/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro\/SS-A. J Clin Pathol. 1999, 52: 684-687. 10.1136\/jcp.52.9.684.","journal-title":"J Clin Pathol"},{"key":"2402_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2003.10.005","volume":"110","author":"LM Stinton","year":"2004","unstructured":"Stinton LM, Eystathioy T, Selak S, Chan EK, Fritzler MJ: Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol. 2004, 110: 30-44. 10.1016\/j.clim.2003.10.005.","journal-title":"Clin Immunol"},{"key":"2402_CR32","first-page":"675","volume":"16","author":"L Kong","year":"1998","unstructured":"Kong L, Robinson CP, Peck AB, Vela-Roch N, Sakata KM, Dang H, Talal N, Humphreys-Beher MG: Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol. 1998, 16: 675-681.","journal-title":"Clin Exp Rheumatol"},{"key":"2402_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/phrs.2000.0757","volume":"43","author":"R Schulz","year":"2001","unstructured":"Schulz R: The pharmacology of phosducin. Pharmacol Res. 2001, 43: 1-10. 10.1006\/phrs.2000.0757.","journal-title":"Pharmacol Res"},{"key":"2402_CR34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.exer.2005.11.002","volume":"82","author":"S Gobeil","year":"2006","unstructured":"Gobeil S, Letartre L, Raymond V: Functional analysis of the glaucoma-causing TIGR\/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion. Exp Eye Res. 2006, 82: 1017-1029. 10.1016\/j.exer.2005.11.002.","journal-title":"Exp Eye Res"},{"key":"2402_CR35","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/art.1780371114","volume":"37","author":"L Llorente","year":"1994","unstructured":"Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sj\u00f6gren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994, 37: 1647-1655. 10.1002\/art.1780371114.","journal-title":"Arthritis Rheum"},{"key":"2402_CR36","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1002\/eji.200737229","volume":"37","author":"K Yoshihara","year":"2007","unstructured":"Yoshihara K, Yamada H, Hori A, Yajima T, Kubo C, Yoshikai Y: IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17. Eur J Immunol. 2007, 37: 2744-2752. 10.1002\/eji.200737229.","journal-title":"Eur J Immunol"},{"key":"2402_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1089\/104303403322542257","volume":"14","author":"MR Kok","year":"2003","unstructured":"Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ: Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sj\u00f6gren's syndrome. Hum Gene Ther. 2003, 14: 1605-1618. 10.1089\/104303403322542257.","journal-title":"Hum Gene Ther"},{"key":"2402_CR38","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1167\/iovs.03-0755","volume":"45","author":"Z Zhu","year":"2004","unstructured":"Zhu Z, Stevenson D, Schechter JE, Mircheff AK, Ritter T, Labree L, Trousdale MD: Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis. Invest Ophthalmol Vis Sci. 2004, 45: 1375-1381. 10.1167\/iovs.03-0755.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2402_CR39","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1002\/j.1460-2075.1994.tb06715.x","volume":"13","author":"PR Baum","year":"1994","unstructured":"Baum PR, Gayle RB, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Baker E, Sutherland GR, Clifford KN, Alderson MR, Goodwin RG, Fanslow WC: Molecular characterization of murine and human OX40\/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994, 13: 3992-4001.","journal-title":"EMBO J"},{"key":"2402_CR40","doi-asserted-by":"publisher","first-page":"13138","DOI":"10.1073\/pnas.0603107103","volume":"103","author":"T Ito","year":"2006","unstructured":"Ito T, Wang YH, Duramad O, Hanabuchi S, Perng OA, Gilliet M, Qin FX, Liu YJ: OX40 ligand shuts down IL-10-producing regulatory T cells. Proc Natl Acad Sci USA. 2006, 103: 13138-13143. 10.1073\/pnas.0603107103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2402_CR41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nature07036","volume":"453","author":"E Bettelli","year":"2008","unstructured":"Bettelli E, Korn T, Oukka M, Kuchroo VK: Induction and effector functions of T(H)17 cells. Nature. 2008, 453: 1051-1057. 10.1038\/nature07036.","journal-title":"Nature"},{"key":"2402_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/art.23214","volume":"58","author":"CQ Nguyen","year":"2008","unstructured":"Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB: Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sj\u00f6gren's syndrome: findings in humans and mice. Arthritis Rheum. 2008, 58: 734-743. 10.1002\/art.23214.","journal-title":"Arthritis Rheum"},{"key":"2402_CR43","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","volume":"181","author":"S Xiao","year":"2008","unstructured":"Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK: Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol. 2008, 181: 2277-2284.","journal-title":"J Immunol"},{"key":"2402_CR44","unstructured":"Nguyen CQ, Ashok S, She JX, McIndoe RA, Peck AB: Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sj\u00f6gren's syndrome (SjS)-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse. Exp Eye Res."},{"key":"2402_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/rheumatology\/kei190","volume":"45","author":"BM Lodde","year":"2006","unstructured":"Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR: Serum lipid levels in Sj\u00f6gren's syndrome. Rheumatology (Oxford). 2006, 45: 481-484. 10.1093\/rheumatology\/kei190.","journal-title":"Rheumatology (Oxford)"},{"key":"2402_CR46","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bbamem.2006.03.026","volume":"1758","author":"Y Ishikawa","year":"2006","unstructured":"Ishikawa Y, Cho G, Yuan Z, Inoue N, Nakae Y: Aquaporin-5 water channel in lipid rafts of rat parotid glands. Biochim Biophys Acta. 2006, 1758: 1053-1060. 10.1016\/j.bbamem.2006.03.026.","journal-title":"Biochim Biophys Acta"},{"key":"2402_CR47","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/labinvest.3700487","volume":"86","author":"SY Killedar","year":"2006","unstructured":"Killedar SY, Eckenrode SE, McIndoe RA, She JX, Nguyen CQ, Peck AB, Cha SR: Early pathogenic events associated with Sj\u00f6gren's syndrome (SjS)-like disease of the nod mouse using microarray analysis. Lab Invest. 2006, 86: 1243-1260. 10.1038\/labinvest.3700487.","journal-title":"Lab Invest"},{"key":"2402_CR48","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm1102-1235","volume":"8","author":"AC Li","year":"2002","unstructured":"Li AC, Glass CK: The macrophage foam cell as a target for therapeutic intervention. Nat Med. 2002, 8: 1235-1242. 10.1038\/nm1102-1235.","journal-title":"Nat Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2560\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:30:57Z","timestamp":1728383457000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2008,12]]}},"alternative-id":["2402"],"URL":"https:\/\/doi.org\/10.1186\/ar2560","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]},"assertion":[{"value":"26 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R137"}}